Review



short-form anxiety and depression instruments  (ProMIS Neurosciences)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ProMIS Neurosciences short-form anxiety and depression instruments
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Short Form Anxiety And Depression Instruments, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pmc11550744-113-3-7?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    short-form anxiety and depression instruments - by Bioz Stars, 2026-07
    90/100 stars

    Images

    1) Product Images from "Health-Related Quality of Life and Perceived Stigma in Eosinophilic Esophagitis: A Real-World, US, Web-Based Survey"

    Article Title: Health-Related Quality of Life and Perceived Stigma in Eosinophilic Esophagitis: A Real-World, US, Web-Based Survey

    Journal: Gastro Hep Advances

    doi: 10.1016/j.gastha.2024.07.015

    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation.
    Figure Legend Snippet: Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation.

    Techniques Used: Derivative Assay, Standard Deviation



    Similar Products

    short-form anxiety and depression instruments  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences short-form anxiety and depression instruments
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Short Form Anxiety And Depression Instruments, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pmc11550744-113-3-7?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    short-form anxiety and depression instruments - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    short-form instruments of anxiety  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences short-form instruments of anxiety
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Short Form Instruments Of Anxiety, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pm37857547-71-31-35?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    short-form instruments of anxiety - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    anxiety and depression instruments 8-item short form  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences anxiety and depression instruments 8-item short form
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Anxiety And Depression Instruments 8 Item Short Form, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pm37526959-185-2-6?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    anxiety and depression instruments 8-item short form - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    short-form instruments of physical function, depression and anxiety  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences short-form instruments of physical function, depression and anxiety
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Short Form Instruments Of Physical Function, Depression And Anxiety, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pmc10603521__bmjopen___2023___075921__draft_revisions-169-20-24?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    short-form instruments of physical function, depression and anxiety - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    patient-reported outcomes measurement information adult depression and anxiety short form instruments (promis)  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences patient-reported outcomes measurement information adult depression and anxiety short form instruments (promis)
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Patient Reported Outcomes Measurement Information Adult Depression And Anxiety Short Form Instruments (Promis), supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pmc09773944-354-17-20?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    patient-reported outcomes measurement information adult depression and anxiety short form instruments (promis) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    anxiety instrument short form 4a  (ProMIS Neurosciences)
    90
    ProMIS Neurosciences anxiety instrument short form 4a
    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported <t>Outcomes</t> <t>Measurement</t> <t>Information</t> <t>System;</t> SD, standard deviation.
    Anxiety Instrument Short Form 4a, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/short+form+instruments+anxiety/pm36194947-48-6-5?v=ProMIS+Neurosciences
    Average 90 stars, based on 1 article reviews
    anxiety instrument short form 4a - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation.

    Journal: Gastro Hep Advances

    Article Title: Health-Related Quality of Life and Perceived Stigma in Eosinophilic Esophagitis: A Real-World, US, Web-Based Survey

    doi: 10.1016/j.gastha.2024.07.015

    Figure Lengend Snippet: Impact of EoE on (A) the domains of vitality, social functioning, and sleep over the past 4 weeks, calculated as derived scores and (B) school/work, social life/leisure activities and family life/home responsibilities over the past 12 months as measured using the Sheehan Disability Scale scores in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]). (C) Derived PROMIS anxiety and depression scores over the past 7 days in adolescents (11–17 years old [caregiver-reported]) and adults (≥18 years old [self-reported]) with EoE. Data are mean (SD). Factors were assessed using the following caregiver- and patient-reported outcome instruments: the impact on sleep was evaluated using 4 questions from the European Health Interview Survey: Developing Common Instruments for Health Surveys ; the impact on social functioning and vitality was assessed using 2 items and 4 items from the 36-Item Short Form Health Survey, respectively; anxiety and depression were assessed using the PROMIS anxiety-8a v1.0 and v2.0, and depression-8b v1.0 and depressive symptoms-6a v2.0 instruments, respectively; and the impact on school/work, social life/leisure activities and family life/home responsibilities was assessed using the three-item Sheehan Disability Scale. , EoE, eosinophilic esophagitis; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation.

    Article Snippet: The 4 Patient-Reported Outcomes Measurement Information System (PROMIS) short-form anxiety and depression instruments evaluated anxiety and depression in adolescents (parent/caregiver proxy versions) and adults over the 7 days before survey completion.

    Techniques: Derivative Assay, Standard Deviation